AI’s role in insurance is already spawning lawsuits and battles over its regulation. That's not slowing down its use.
Ascendis Receives Orphan Drug Exclusivity and Launches YUVIWEL® (Navepegritide) in the United States
YUVIWEL was granted orphan drug exclusivity by U.S. FDA to increase linear growth in pediatric patients 2 years of age and older with ...
But the internet brings me the most joy when I’m surprised — at the posts of others, at being able to see snippets of someone ...
I wasn’t really animated by politics until Trump came along,” G. told me. “I was, like, ‘Wow, America could be something ...
Generare Bioscience SAS, a Paris-based biotechnology company generating never-before-seen molecular data for drug development ...
BelTA visited the simulation and certification center of Gomel State Medical University, where students are taught the principles of first aid as part of the Restart a Heart nationwide campaign.
There are few money managers on Wall Street who have achieved as much as success as D. E. Shaw, a former Columbia University ...
Discover everything about 25 Things Airlines Don't Want Passengers To Know In 2026. Comprehensive guide with facts, insights, ...
AI is advancing at an extraordinary speed. Public confidence is not. McKinsey estimates that generative AI alone could contribute trillions of dollars in annual global economic value. Meanwhile, ...
Visualization, Dimensionality Reduction, Reproducibility, Stability, Multivariate Quantum Data, Information Retrieval ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results